EVER Pharma
everpharma.com
Actively hiring
Oncology Therapeutics
Neurology & CNS Therapeutics
Prescription Drugs
As featured in
View 3 jobs
Claim pageClaim
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials
Overview
EVER Pharma is a global pharmaceutical group with a broad portfolio in neurology, oncology, anaesthesia and intensive care medicine and production and research facilities in Austria and Germany. Its German sales subsidiary in Gröbenzell near Munich markets established therapies and new preparations, and the group hires project managers, accountants and IT and AI specialists. The company is headquartered in Unterach am Attersee, Austria.
News
EVER Pharma Gained EU-Approval of Testosterone Enantate
EVER Pharma, a fully integrated specialty pharmaceuticals company, is pleased toannounce the approval of Testosterone Enantate in the European Union for thetreatment of male hypogonadism. This condition, characterized by insufficienttestosterone productio
Read more
Report
EVER Pharma gained EU-Approval for Advanced Cancer Treatment
EVER Pharma, a fully integrated specialty pharmaceuticals company, announced the approval of Eribulin in the European Union. Eribulin is indicated for the treatment of locally advanced or metastatic breast cancer and unresectable liposarcoma1. Despite adv
Read more
Report
EVER Pharma Announces Approval of Testosterone Undecanoate in the EU
EVER Pharma, a fully integrated specialty pharmaceuticals company, has announced the approval of Testosterone Undecanoate in the European Union for the treatment of male hypogonadism. This therapy, an intramuscular injection with a unique depot formulatio
Read more
Report
EVER Pharma Expands Operations with Opening of New Manufacturing Facility in Jena, Germany
EVER Pharma is proud to announce the official opening of its new manufacturing facility in Jena, Germany, marking a significant milestone in the company's strategic development as a vertically integrated leader in injectables. EVER Pharma has had an activ
Read more
Report
EVER Pharma gains EU Marketing Authorization for Trabectedin
EVER Pharma is pleased to announce the EU-wide marketing authorization of Trabectedin (in 0.25MG and 1MG vial sizes) for the treatment of advanced soft tissue sarcoma and ovarian cancer1. Soft tissue sarcoma (STS) and ovarian cancer are rare forms of canc
Read more
Report
EVER Pharma receives EU approval for a liquid ready to use Bortezomib formulation
EVER Pharma is pleased to announce EU-wide approval of Bortezomib for the treatment of patients with multiple myeloma and mantle cell lymphoma1. Bortezomib EVER Pharma is a liquid ready to use formulation that offers several advantages over the many powde
Read more
Report
World Day of the Critical Lung
EVER Pharma is pleased to support the World Day of the Critical Lung, 1st-2nd December 2021. Access to this virtual event is free and this year the high quality scientific program with internationally recognized experts addresses multiple topics including
Read more
Report
Delegation from Thuringia in Unterach
In the course of a Thuringian economic mission to Austria, the Minister of Economics Wolfgang Tiefensee visited the EVER Pharma Headquarters in Unterach, Austria, on 05 July 2021. The aim of the delegation is to deepen the economic and technological coope
Read more
Report
EVER Pharma receives EU marketing authorization for Azacitidine including a novel presentation to enhance handling efficiency
EVER Pharma is pleased to announce the grant of an EU-wide marketing authorization of Azacitidine for the treatment of patients with myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia1. Azacitidine EVER Pharma is availa
Read more
Report
Show more news
Tech stack
Technologies named in job postings at EVER Pharma over the last 12 months, by layer, with the share of postings for each.
Technologies in use
6
Postings analysed
2
Stack modernity
74/100
Cloud & platforms
Azure
Copilot Studio
OpenAI
Developer tools
Copilot
Practices & domains
Prompt Engineering
RAG
Sign in to see how your skills match this stack
Sign In
Salary insights
Compensation ranges based on this company's open jobs
Median
$61k
Typical range
$54k – $75k
Open positions
4
1
Jobs
Staff
100%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Staff | 1 | $75k | $75k |
Highest paying role
AI Solutions Lead – Business Analyst (m/w/d)
$75k
Normalized to USD per year
People
Mario Breidtscheidel
Geschäftsführer
Georges Kahwati Vertrauliches
Geschäftsführer
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Growth
Hiring Momentum
28/100
Slowing
Open positions
4
0 opened / 0 closed in 30 days
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Analytics
25% ▲
Finance
25% ▲
Management
25% ▲
Enterprise Apps
25% ▲
Offices
Where the company hires and what each office is for
Cities
11
Hiring now
0
Countries
11
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Warsaw
Poland
Regional office
Poland
Almaty
Kazakhstan
Regional office
Kazakhstan
9th flour, 26/1 Bukhar Zhyrau boulevard, Evolution BC, 050021 Almaty, Kazakhstan
Salzburg
Austria
Registered seat
Toledo
Spain
Regional office
Spain
Calle Toledo, Num. 170, Planta 5, Puerta C, 28005 Madrid, Spain
Jena
Germany
Regional office
EVER Pharma Jena GmbH
Burlington
Canada
Regional office
Canada
4145 North Service Road Suite 200 Burlington, L7L 6A3, Ontario, Canada
Jobs
Apply
$75k per year · In office · Full-Time · Austria
Copilot
Prompt Engineering
RAG
Copilot Studio
DevOps
Azure
Management
Agile
Apply
$54k per year · In office · Full-Time · Austria
Copilot
OpenAI
Copilot Studio
DevOps
Azure
Management
SharePoint
Apply